Centre National de Référence CERAINO, Service de Rhumatologie, Hôpital de la Cavale Blanche, BP 824, F 29609, Brest cedex, France.
INSERM UMR1227, Lymphocytes B et Autoimmunité, Université de Bretagne Occidentale, Brest, France.
Arthritis Res Ther. 2017 Dec 6;19(1):269. doi: 10.1186/s13075-017-1475-x.
The objective was to evaluate concordance between 2002 American-European Consensus Group (AECG) and 2016 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for primary Sjögren's syndrome (pSS) and to assess how salivary gland ultrasonography (SGUS) might improve the classification of patients.
Patients with suspected pSS underwent a standardised evaluation, including SGUS, at inclusion into the single-centre Brittany DIApSS cohort. Agreement between the two criteria sets was assessed using Cohen's κ coefficient. Characteristics of discordantly categorised patients were detailed.
We prospectively included 290 patients between 2006 and 2016, among whom 125 (43%) met ACR/EULAR criteria and 114 (39%) also met AECG criteria; thus, 11 (4%) patients fulfilled only ACR/EULAR, no patients AECG only, and 165 (57%) patients neither criteria set. Concordance was excellent (κ = 0.92). Compared to patients fulfilling both criteria sets, the 11 patients fulfilling only ACR/EULAR criteria had similar age and symptom duration but lower frequencies of xerophthalmia and xerostomia (p < 0.01 for each) and salivary gland dysfunction (p < 0.01); most had systemic involvement (91%), including three (27%) with no sicca symptoms; 91% had abnormal salivary gland biopsy and 46% anti-Sjögren's-syndrome-related antigen A (anti-SSA); 64% were diagnosed with pSS by the physician. SGUS was abnormal in 12% of the 165 patients fulfilling no criteria set. Including SGUS among the ACR/EULAR criteria increased sensitivity from 87.4% to 91.1% when physician diagnosis was the reference standard.
Agreement between AECG and ACR/EULAR criteria sets is excellent. ACR/EULAR criteria are slightly more sensitive and classified some patients without sicca symptoms as having pSS. Including SGUS in the ACR/EULAR criteria may further improve their sensitivity.
本研究旨在评估 2002 年美国-欧洲共识组(AECG)和 2016 年美国风湿病学会(ACR)/欧洲抗风湿病联盟(EULAR)原发性干燥综合征(pSS)分类标准之间的一致性,并评估唾液腺超声(SGUS)对患者分类的影响。
纳入的疑似 pSS 患者在单中心布列塔尼 DIApSS 队列入组时接受了标准评估,包括 SGUS。采用 Cohen κ 系数评估两种标准之间的一致性。详细描述分类不一致患者的特征。
我们前瞻性纳入了 2006 年至 2016 年的 290 例患者,其中 125 例(43%)符合 ACR/EULAR 标准,114 例(39%)也符合 AECG 标准;因此,11 例(4%)患者仅符合 ACR/EULAR 标准,无患者仅符合 AECG 标准,165 例(57%)患者两种标准均不符合。一致性极好(κ=0.92)。与同时符合两种标准的患者相比,仅符合 ACR/EULAR 标准的 11 例患者的年龄和症状持续时间相似,但干眼症和口干症的发生率较低(每项均<0.01),唾液腺功能障碍的发生率也较低(均<0.01);大多数患者有系统性受累(91%),包括 3 例(27%)无干燥症状;91%的患者唾液腺活检异常,46%抗干燥综合征相关抗原 A(抗-SSA)阳性;64%的患者被医生诊断为 pSS。在未符合任何标准的 165 例患者中,12%的患者 SGUS 异常。当以医生诊断为参考标准时,将 SGUS 纳入 ACR/EULAR 标准可将敏感性从 87.4%提高至 91.1%。
AECG 和 ACR/EULAR 标准之间的一致性极好。ACR/EULAR 标准的敏感性略高,并将一些无干燥症状的患者归类为 pSS。将 SGUS 纳入 ACR/EULAR 标准可能进一步提高其敏感性。